Hansa Biopharma to host conference call to provide interim results for January-September 2021 and Business Update
LUND, Sweden, Oct. 7, 2021 /PRNewswire/ — Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-September 2021 at 8:00 CET on October 21, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
Access to content from the Arctic Knowledge Archives is available to Passport holders only.
Arctic Today is a non-profit organization, supported by donations from readers like you. While we strongly believe in giving free access to current news for all readers, we reserve content older than one year for our supporters. All individual contributions of at least $15/month or $150/year will receive a Passport to the Arctic Knowledge Archives. Help us drive the leading non-profit editorial team dedicated to delivering context, information and analysis about events in the Arctic.
Already have a Passport? Sign in
choose your level of support and unlock your Arctic Passport.
Individual Annual
$1.00
Year
Individual Monthly
$15.00
Month
